Kev tshawb nrhiav ua ke ntawm EBV-VCA-IGA, EBV-EA-IGA thiab EB-NA1-IgA tag nrho npog EBV gene spectrum, uas zoo txhim kho qhov rhiab heev thiab tshwj xeeb ntawm nasopharyngeal carcinoma nrhiav kom tau.

xov xwm 2 (1)

Nasopharyngeal (nay-zoh-fuh-RIN-jee-ul) carcinoma yog mob qog noj ntshav uas tshwm sim hauv nasopharynx, uas nyob tom qab koj lub qhov ntswg thiab sab nraub qaum ntawm koj caj pas.
Nasopharyngeal carcinoma tsis tshua muaj nyob hauv Tebchaws Meskas.Nws tshwm sim ntau zaus hauv lwm qhov chaw ntawm lub ntiaj teb - tshwj xeeb tshaj yog Southeast Asia.

Nasopharyngeal carcinoma yog qhov nyuaj rau kuaj pom ntxov.Qhov no tej zaum yog vim qhov nasopharynx tsis yooj yim rau kev kuaj xyuas thiab cov tsos mob ntawm nasopharyngeal carcinoma ua rau lwm yam mob ntau dua.
Nasopharyngeal carcinoma feem ntau tshwm sim hauv cov hnub nyoog nruab nrab thiab cov neeg laus hnub nyoog tshaj 40 xyoo, thiab muaj cov yam ntxwv hauv cheeb tsam thiab tsev neeg, thiab qhov tshwm sim hauv Guangdong yog thawj zaug hauv Suav teb, tseem hu ua "Guangdong cancer".

1.Cov lus qhia rau kev kuaj mob thiab kev kho mob ntawm Nasopharyngeal carcinoma

Nyob rau hauv 2021 Cov Lus Qhia rau Kev Ntsuas thiab Kev Kho Mob Nasopharyngeal Carcinoma, Tuam Tshoj Society of Clinical Oncology (CSCO) suav nrog cov txheej txheem tshawb nrhiav serological hauv Class I pov thawj rau kev kuaj mob ntawm nasopharyngeal carcinoma, thiab taw qhia tias kev sib xyaw ntawm EB-VCA-IgA thiab EB-NA1-IgA cov tshuaj tiv thaiv kab mob EB-tus kab mob tuaj yeem nce qhov kev kuaj mob ntxov ntawm nasopharyngeal carcinoma los ntawm 3 zaug (21% ~ 79%) thiab txo qhov kev pheej hmoo ntawm kev tuag los ntawm 88%!Xyoo 2019 Cov Kws Tshaj Lij Pom Zoo ntawm Daim Ntawv Thov Kev Kho Mob ntawm Cov Cim rau Nasopharyngeal Carcinoma kuj tau taw qhia tias EBV-EA-IgA yog ib qho cim ntawm EBV tsis ntev los no los yog nquag loj hlob ntawm EBV, nrog rau qib siab ntawm qhov tshwj xeeb, thiab feem ntau siv rau kev kuaj mob qog noj ntshav nasopharyngeal. thiab kev kuaj mob ntxov.

xov xwm 2 (2)

Txoj kev tshawb no qhia tau hais tias peb qhov kev sib koom ua ke ntawm EBV-VCA-IGA, EBV-EA-IGA thiab EB-NA1-IgA tag nrho npog EBV gene spectrum, uas zoo txhim kho qhov rhiab heev thiab tshwj xeeb ntawm nasopharyngeal carcinoma nrhiav pom, txo qis kev kuaj pom, xyuas kom meej. Qhov tseeb ntawm kev kwv yees kab mob, thiab kwv yees qhov tshwm sim ntawm tus kab mob 5-10 xyoo ua ntej, uas yog tsim rau kev kuaj mob qog noj ntshav hauv nasopharyngeal loj.

2.Tus VCA-IgA + EA-IgA + NA1-IgA tsim los ntawm Beijing Beier tuaj yeem muab cov txheej txheem kuaj mob ntxov rau Nasopharyngeal Carcinoma.

Magnetism particulate immuno chemistry luminescence method

Khoom npe Cov ntawv luv
EB Virus VCA-IgA Antibody Detection Kit EB-VCA-IgA
EB Virus EA-IgA Antibody Detection Kit EB-EA-IgA
EB Virus NA1-IgA Antibody Detection Kit EB-NA1-IgA

Txoj kev Elisa:

Khoom npe Cov ntawv luv
EB Virus VCA-IgA Elisa Kit EB-VCA-IgA
EB Virus EA-IgA Elisa Kit EB-EA-IgA
EB Virus NA1-IgA Elisa Kit EB-NA1-IgA

3.Product Performance

Cov khoom siv kuaj VCA-IgA tsim los ntawm Beijing Beier tuaj yeem hloov cov khoom siv EU tus qauv rau kev kuaj pom ntxov thiab tshuaj xyuas ntawm nasopharyngeal carcinoma.
British Medical Journal (BMJ) (qhov cuam tshuam txog 16.378) yog Ib qho ntawm plaub phau ntawv kho mob hauv ntiaj teb.Nyob rau hauv 2017, ib pab neeg tshawb fawb tau luam tawm ib daim ntawv nyob rau hauv British Medical Journal (BMJ) "Kev ntsuam xyuas ntawm xya recombinant VCA-IgA ELISA cov khoom siv rau kev kuaj mob ntawm nasopharyngeal carcinoma hauv Suav teb: ib rooj plaub-tswj kev sim".
Hauv daim ntawv no, 200 tus neeg mob uas muaj mob qog noj ntshav nasopharyngeal (NPC) thiab 200 tus qauv tib neeg cov ntshav ntshav (SYSUCC) los ntawm Sun Yat-sen University Cancer Center tau kawm thiab sim, thiab kev ua haujlwm ntawm EB-VCA-IgA (ELISA) cov khoom siv ua los ntawm 8 cov tuam txhab lag luam hauv kev lag luam hauv tsev tau muab piv rau kev ntsuas kev ua tau zoo.Qhov xaus yog tias cov khoom siv EBV-VCA-IgA (ELISA) tsim los ntawm Beijing Beier muaj tib yam kev kuaj mob raws li EBV-VCA-IgA (ELISA) uas tsim los ntawm cov khoom siv txawv teb chaws Oumeng, thiab EBV-VCA-IgA (ELISA) Cov khoom siv uas tsim los ntawm Beijing Beier tuaj yeem hloov cov khoom siv txawv teb chaws rau kev tshawb pom ntxov thiab tshuaj xyuas ntawm nasopharyngeal carcinoma.Cov ntaub ntawv ntawm cov tuam txhab lag luam koom nrog hauv kev xeem tau pom nyob rau hauv Table 1, cov txiaj ntsig kev xeem tau pom nyob rau hauv Table 2, thiab cov lus txiav txim siab tau qhia hauv Table 3.

xov xwm 2 (3)
xov xwm 2 (4)

Test Conclusion

Peb recombinant VCA-IgA cov khoom siv-BB, HA thiab KSB- tau kuaj pom qhov sib npaug ntawm cov khoom siv txheem.Lawv tuaj yeem hloov pauv rau cov khoom siv txheem thiab lawv cov kev sib xyaw ua ke tuaj yeem siv rau kev tshawb nrhiav thaum ntxov thiab tshuaj ntsuam rau NPC.


Post lub sij hawm: Feb-23-2023